AR027525A1 - Tableta y procedimiento para fabricar la misma - Google Patents
Tableta y procedimiento para fabricar la mismaInfo
- Publication number
- AR027525A1 AR027525A1 ARP010100626A ARP010100626A AR027525A1 AR 027525 A1 AR027525 A1 AR 027525A1 AR P010100626 A ARP010100626 A AR P010100626A AR P010100626 A ARP010100626 A AR P010100626A AR 027525 A1 AR027525 A1 AR 027525A1
- Authority
- AR
- Argentina
- Prior art keywords
- tablet
- procedure
- manufacture
- same
- binder
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Una tableta y un procedimiento para fabricar la misma; la tableta se hace a partir de un aglomerado que comprende una mezcla de por lo menos un ingredienteactivo y un aglutinante; el aglomerado granulado se calienta para fundir el aglutinante solo en o cerca de su superficie, y después se enfría, de tal maneraque el aglutinante fundido se solidifique en una fase continua, formando así una capa fusionada sobre el exterior de la tableta.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/502,594 US6258381B1 (en) | 2000-02-11 | 2000-02-11 | Tablet and process for making the same |
Publications (1)
Publication Number | Publication Date |
---|---|
AR027525A1 true AR027525A1 (es) | 2003-04-02 |
Family
ID=23998514
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP010100626A AR027525A1 (es) | 2000-02-11 | 2001-02-12 | Tableta y procedimiento para fabricar la misma |
Country Status (9)
Country | Link |
---|---|
US (1) | US6258381B1 (es) |
EP (1) | EP1123699B1 (es) |
AR (1) | AR027525A1 (es) |
AT (1) | ATE361058T1 (es) |
BR (1) | BR0103001A (es) |
CA (1) | CA2335179C (es) |
DE (1) | DE60128168T2 (es) |
ES (1) | ES2286077T3 (es) |
PT (1) | PT1123699E (es) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6555139B2 (en) | 1999-06-28 | 2003-04-29 | Wockhardt Europe Limited | Preparation of micron-size pharmaceutical particles by microfluidization |
US20030060422A1 (en) | 2001-08-31 | 2003-03-27 | Balaji Venkataraman | Tannate compositions and methods of treatment |
US7049435B2 (en) | 2002-03-08 | 2006-05-23 | Tate & Lyle Public Limited Company | Extractive methods for purifying sucralose |
US6998480B2 (en) | 2002-03-08 | 2006-02-14 | Tate & Lyle Public Limited Company | Process for improving sucralose purity and yield |
US20050031686A1 (en) * | 2002-03-25 | 2005-02-10 | Truffini & Regge' Farmaceutici Srl | Gastroresistant tablets for alimentary, dietetic and therapeutic use |
US20040109889A1 (en) * | 2002-12-04 | 2004-06-10 | Bunick Frank J. | Surface treatment composition for soft substrates |
US20040258822A1 (en) * | 2003-06-16 | 2004-12-23 | Shyhyuan Liao | Chilsonated sucralose product |
US9241902B2 (en) * | 2003-12-17 | 2016-01-26 | R.P. Scherer Technologies, Llc | Chewable soft capsules containing ungelatinized starch |
US7750146B2 (en) * | 2005-03-18 | 2010-07-06 | Tate & Lyle Plc | Granular sucralose |
GB0515492D0 (en) * | 2005-07-28 | 2005-08-31 | Reckitt Benckiser Healthcare | Improvements in or relating to compositions,articles and methods |
US20070077300A1 (en) * | 2005-09-30 | 2007-04-05 | Wynn David W | Oral compositions containing a salivation inducing agent |
US20070264403A1 (en) * | 2006-05-11 | 2007-11-15 | Nehmer Warren L | Sparkling agglomerated sweetener, and method of making it |
US20090060983A1 (en) * | 2007-08-30 | 2009-03-05 | Bunick Frank J | Method And Composition For Making An Orally Disintegrating Dosage Form |
EP2217213B1 (en) * | 2007-10-31 | 2017-05-24 | Johnson & Johnson Consumer Inc. | Orally disintegrative dosage form |
AR070082A1 (es) * | 2008-01-04 | 2010-03-10 | Tate & Lyle Technology Ltd | Metodo para la produccion de sucralosa |
CN101977664B (zh) * | 2008-03-20 | 2014-02-26 | 塔特和莱利技术有限公司 | 从叔酰胺溶剂中去除酸 |
US8436157B2 (en) * | 2008-03-26 | 2013-05-07 | Tate & Lyle Technology Limited | Method for the production of sucralose |
JP5653341B2 (ja) * | 2008-04-03 | 2015-01-14 | テート アンド ライル テクノロジー リミテッド | スクラロース抽出効率に対する炭水化物濃度の影響 |
AR071134A1 (es) * | 2008-04-03 | 2010-05-26 | Tate & Lyle Technology Ltd | Cristalizacion de sucralosa a partir de chorros que contienen sucralosa |
WO2009124113A1 (en) * | 2008-04-03 | 2009-10-08 | Tate & Lyle Technology Ltd. | Extraction of less polar impurities from sucralose containing aqueous feed streams |
US8497367B2 (en) * | 2008-04-03 | 2013-07-30 | Tate & Lyle Technology Limited | Sucralose purification process |
GB2469158B (en) | 2009-03-31 | 2011-09-28 | Peter J Seaberg | Base-assisted formation of tin-sucrose adducts |
US8858210B2 (en) | 2009-09-24 | 2014-10-14 | Mcneil-Ppc, Inc. | Manufacture of variable density dosage forms utilizing radiofrequency energy |
US20110070286A1 (en) * | 2009-09-24 | 2011-03-24 | Andreas Hugerth | Process for the manufacture of nicotine-comprising chewing gum and nicotine-comprising chewing gum manufactured according to said process |
US8313768B2 (en) * | 2009-09-24 | 2012-11-20 | Mcneil-Ppc, Inc. | Manufacture of tablet having immediate release region and sustained release region |
US8343533B2 (en) | 2009-09-24 | 2013-01-01 | Mcneil-Ppc, Inc. | Manufacture of lozenge product with radiofrequency |
AU2015203155B2 (en) * | 2009-09-24 | 2017-05-11 | Mcneil-Ppc, Inc. | Orally transformable tablets |
GB2474311B (en) * | 2009-10-12 | 2012-10-17 | Tate & Lyle Technology Ltd | Low temperature, single solvent process for the production of sucrose-6-ester |
GB2474310B (en) | 2009-10-12 | 2012-02-29 | Tate & Lyle Technology Ltd | Process for the production of sucrose-6-ester |
GB201110520D0 (en) | 2011-05-10 | 2011-08-03 | Tate & Lyle Technology Ltd | Extraction of carboxylic acids with tin compounds |
US9511028B2 (en) | 2012-05-01 | 2016-12-06 | Johnson & Johnson Consumer Inc. | Orally disintegrating tablet |
US9445971B2 (en) | 2012-05-01 | 2016-09-20 | Johnson & Johnson Consumer Inc. | Method of manufacturing solid dosage form |
US9233491B2 (en) | 2012-05-01 | 2016-01-12 | Johnson & Johnson Consumer Inc. | Machine for production of solid dosage forms |
MX368159B (es) | 2014-01-10 | 2019-09-20 | Johnson & Johnson Consumer Inc | Proceso para elaborar tabletas con el uso de radiofrecuencia y partículas disipativas revestidas. |
US10493026B2 (en) | 2017-03-20 | 2019-12-03 | Johnson & Johnson Consumer Inc. | Process for making tablet using radiofrequency and lossy coated particles |
CN108853038A (zh) * | 2018-08-06 | 2018-11-23 | 成都通德药业有限公司 | 一种对乙酰氨基酚片及其制备工艺 |
WO2023200954A1 (en) | 2022-04-13 | 2023-10-19 | Aprecia Pharmaceuticals LLC | System and method for additive manufacturing using an omnidirectional magnetic movement apparatus |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK123806B (da) * | 1970-06-08 | 1972-08-07 | Pharmacia As | Fremgangsmåde til fremstilling af tabletter eller piller med langsom afgivelse af et aktivt stof. |
US4327076A (en) | 1980-11-17 | 1982-04-27 | Life Savers, Inc. | Compressed chewable antacid tablet and method for forming same |
EP0070127A3 (en) | 1981-07-10 | 1983-08-17 | Beecham Group Plc | Tablets |
US4609543A (en) | 1983-11-14 | 1986-09-02 | Nabisco Brands, Inc. | Soft homogeneous antacid tablet |
HU191246B (en) * | 1984-02-21 | 1987-01-28 | Alkaloida Vegyeszeti Gyara,Hu | Process for producing oral pharmaceutical compositions of retaed activity |
US4684534A (en) | 1985-02-19 | 1987-08-04 | Dynagram Corporation Of America | Quick-liquifying, chewable tablet |
US4828845A (en) | 1986-12-16 | 1989-05-09 | Warner-Lambert Company | Xylitol coated comestible and method of preparation |
NZ234587A (en) * | 1989-08-04 | 1991-11-26 | Mcneil Ppc Inc | A chewable pharmaceutical tablet of compressed coated granules |
JP2948317B2 (ja) | 1991-05-28 | 1999-09-13 | マクニール―ピーピーシー・インコーポレーテツド | 噛める薬物投与用組成物 |
ES2096103T3 (es) | 1992-01-13 | 1997-03-01 | Pfizer | Preparacion de comprimidos de resistencia incrementada. |
US6177104B1 (en) * | 1994-01-27 | 2001-01-23 | The Board Of Regents Of The University Of Oklahoma | Particulate support matrix for making a rapidly dissolving dosage form |
US6024981A (en) | 1997-04-16 | 2000-02-15 | Cima Labs Inc. | Rapidly dissolving robust dosage form |
EP1017386A1 (en) | 1997-10-02 | 2000-07-12 | H. Lundbeck A/S | GRANULAR PREPARATIONS OF 5-(2-ETHYL- 2$i(H)-TETRAZOL- 5-YL)-1-METHYL-1, 2,3,6-TETRAHYDROPYRIDINE |
US6060078A (en) | 1998-09-28 | 2000-05-09 | Sae Han Pharm Co., Ltd. | Chewable tablet and process for preparation thereof |
-
2000
- 2000-02-11 US US09/502,594 patent/US6258381B1/en not_active Expired - Lifetime
-
2001
- 2001-02-09 ES ES01301144T patent/ES2286077T3/es not_active Expired - Lifetime
- 2001-02-09 DE DE60128168T patent/DE60128168T2/de not_active Expired - Lifetime
- 2001-02-09 CA CA002335179A patent/CA2335179C/en not_active Expired - Fee Related
- 2001-02-09 EP EP01301144A patent/EP1123699B1/en not_active Expired - Lifetime
- 2001-02-09 PT PT01301144T patent/PT1123699E/pt unknown
- 2001-02-09 AT AT01301144T patent/ATE361058T1/de not_active IP Right Cessation
- 2001-02-12 AR ARP010100626A patent/AR027525A1/es not_active Application Discontinuation
- 2001-02-12 BR BR0103001-9A patent/BR0103001A/pt not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2335179A1 (en) | 2001-08-11 |
EP1123699A3 (en) | 2003-01-22 |
DE60128168T2 (de) | 2008-01-03 |
DE60128168D1 (de) | 2007-06-14 |
CA2335179C (en) | 2008-12-02 |
US6258381B1 (en) | 2001-07-10 |
BR0103001A (pt) | 2002-03-05 |
ES2286077T3 (es) | 2007-12-01 |
EP1123699A2 (en) | 2001-08-16 |
ATE361058T1 (de) | 2007-05-15 |
EP1123699B1 (en) | 2007-05-02 |
PT1123699E (pt) | 2007-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR027525A1 (es) | Tableta y procedimiento para fabricar la misma | |
IL181117A (en) | Sustained drug release composition demonstrating an ascending zero order release pattern and methods of manufacturing such a composition | |
ATE362841T1 (de) | Mehrsschichtfolie enthaltend amorphes polymer | |
DE60234558D1 (de) | Brennkammerhemd mit hybrider Filmkühlung | |
BRPI0411548A (pt) | stent polimérico e método de fabricação | |
AR057443A1 (es) | Composiciones de pelicula laminada, envases preparados a partir de las mismas y metodo de uso | |
AR012596A1 (es) | Comprimidos bio-adhesivos, procedimiento para prepararlos y sus aplicaciones | |
AU5086401A (en) | Multiple layer film of a new non-pvc material | |
SV1998000052A (es) | Pildoras entericas de fluoxetina ref. x-10709 | |
DE60142055D1 (de) | Temperaturkompensationsoszillator | |
DE69912311D1 (de) | Galantamin-zusammensetzung mit gesteuerter freisetzung | |
AU2002232415A1 (en) | Magnetic substrates, composition and method for making the same | |
BR0311437A (pt) | Tts de fusão a quente para a administração de rotigotina | |
CO5251445A1 (es) | Forma de estado solido de celecoxib que tiene mejorada biodisponibilidad | |
BG103881A (en) | Method for the preparation of elurbiprophene pastills | |
UA26449C2 (uk) | Тверда лікарська форма для оральhого застосуваhhя з сповільhеhим вивільhеhhям активhої речовиhи і спосіб її виготовлеhhя (варіаhти) | |
WO2002098391A3 (en) | Process for preparing granular compositions | |
ES2183525T3 (es) | Articulo ceramico resistente al choque termico. | |
AU2001251096A1 (en) | Thermally degradable epoxy underfills for flip-chip applications | |
BR0015630B1 (pt) | material refratÁrio isolante, artigo, e, composiÇço aquosa para a fabricaÇço de um material refratÁrio isolante. | |
EP1552913A4 (en) | METHOD FOR PRODUCING A CERAMIC FORMK RPTER | |
GB0106469D0 (en) | Solid formulation | |
DE60107119D1 (de) | Thermisch übertragbare zusammensetzungen und verfahren | |
WO2002022107A3 (en) | Pharmaceutical composition having modified carrier | |
GB0002133D0 (en) | A composition for use in the manufacture of thermally insulating refractory articles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |